Other News

Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction

DANVERS, Mass.–(BUSINESS WIRE)–The Restore EF Study demonstrates the use of contemporary best practices, including attempting a more complete revascularization with Impella-supported high-risk PCI, is associated with significant improvement of left ventricular ejection fraction (LVEF), heart failure symptoms, and anginal symptoms at follow up. The interim analysis was presented today by Mitul […]

Large Study Demonstrates Exceptional Safety and High Procedural Success With Cardiovascular Systems’ Diamondback 360® Coronary Orbital Atherectomy System (OAS)

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observational study of coronary orbital atherectomy were released at TCT Connect 2020. The presentation, authored […]

Dr. Eugene Tanquilut Performs First Ever Ground-Breaking TCAR Procedure in Chicago Southland

Stroke Risk Is Dramatically Reduced During and After Carotid Artery Stenting with Innovative New Procedure TINLEY PARK, Ill.–(BUSINESS WIRE)–When Delnora Kizzee Talbert met Dr. Eugene Tanquilut in 2017, neither of them had any idea that in 3 short years they would be making history together. “I’ll never forget meeting Dr. T,” says […]

LivaNova Confirms Receipt of Letter from PrimeStone Capital

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today confirmed receipt of a letter from PrimeStone Capital LLP (PrimeStone) to its Board of Directors and issued the following statement: “LivaNova welcomes open communication and values constructive input toward the goal of enhancing value for all LivaNova shareholders. […]

Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing

Company accelerates development of its nanoparticle-based drug delivery technology platform to treat peripheral artery disease and other applications LOS GATOS, Calif.–(BUSINESS WIRE)–Advanced NanoTherapies, Inc., a privately-held medical device company committed to exploring nanotechnology for enhanced drug uptake and sustained retention, today announced it has closed on the final tranche of […]

Itamar™ Medical Announces Third Quarter Preliminary Revenue Results and Reinstates Revenue Guidance for Full Year 2020

Q3 Total Revenue Results of $10.7M to $11.0M, reflecting growth of 32%-36% Q3 U.S. WatchPAT Revenue Results of $8.6M to $8.9M, reflecting growth of 51%-56% Full Year 2020 Revenue Guidance of $39.5M to $40.5M CAESAREA, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) —  Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a leading medical device and digital health company focused on the diagnosis […]

InspireMD Announces Renowned Interventional Cardiologist Gary S. Roubin, M.D., Ph.D., to Join Board of Directors

TEL AVIV, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the addition of Gary Roubin, M.D., Ph.D., to InspireMD’s Board of Directors. Dr. Gary […]

Brain Scientific Seeks FDA Approval of Next-Gen NeuroCap™ EEG Cap Amidst New Data on Neurological Problems in COVID Patients

NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has submitted a premarket 510(k) application to the United States Food and Drug Administration for its next generation NeuroCap™ device. NeuroCap™ is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in […]

WaveClear, Inc Raises $1.125 Million in Series-A Funding Led by Hunniwell Lake Ventures

SAN FRANCISCO, Oct. 13, 2020 /PRNewswire/ — WaveClear, Inc., a medical device start-up pioneering the deployment of therapeutic ultrasound technologies to combat vascular diseases, recently announced today the closing of a $1,125,000 Series-A round of investment led by Palo Alto-based medical device venture capital firm, Hunniwell Lake Ventures (“HLV”). Peripheral vascular diseases are increasing worldwide, and […]